Musculoskeletal tumors: Use of proton MR spectroscopic imaging for characterization
Open Access
- 28 November 2005
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 23 (1) , 23-28
Abstract
Purpose To determine the value of multivoxel proton magnetic resonance spectroscopic imaging (MRSI) in distinguishing malignant skeletal tumors from benign tumors and normal bone marrow using the metabolite choline (Cho) as a marker for malignancy. Materials and Methods Pathologic specimens obtained from 13 patients who had undergone wide resection for skeletal tumors underwent evaluation by MRSI at 1.5 T. Coronal T1‐weighted gradient‐echo sequence obtained for localization purposes (TR/TE = 250/1.8 msec, field of view [FOV] = 18 × 18), and single‐slice MRSI (TR/TE = 2000/272 msec, FOV = 18 × 18, 10‐mm slice‐thickness) were performed. Water, lipid, and Cho images were reconstructed from MRSI data. Cho signal was measured in each specimen and expressed relative to background noise level (signal‐to‐noise ratio [SNR]) where noise was measured between 7.0 and 9.0 ppm. Cho SNRs were compared between areas containing malignant tumor and nonmalignant tissue (benign lesion or normal bone marrow) as determined by histopathology. Results Specimens included 13 skeletal sarcomas (seven osteosarcomas, three chondrosarcomas, one malignant fibrous histiocytoma, one fibrosarcoma, and one leiomyosarcoma). All specimens included a sample of normal bone marrow and two specimens also contained benign lesions. All sarcomas demonstrated a signal at 3.2 ppm assigned to Cho‐containing metabolites in areas of malignancy. Peak Cho SNR was significantly different for areas containing histologically‐proven malignancy compared to nonmalignant tissue (9.8 ± 5.1 vs. 2.7 ± 1.4, respectively, P < 0.002). Conclusion These preliminary results indicate that MRSI at 1.5 T is a promising noninvasive method of differentiating malignant skeletal tumors from nonmalignant tissue. Using MRSI, Cho can be detected in skeletal tumors and may serve as a marker for malignancy. J. Magn. Reson. Imaging 2006.Keywords
This publication has 18 references indexed in Scilit:
- Characterization of Bone and Soft-Tissue Tumors with in Vivo1H MR Spectroscopy: Initial ResultsRadiology, 2004
- Pathologic Characterization of Human Prostate Tissue with Proton MR SpectroscopyRadiology, 2003
- Normal Lumbar Vertebrae: Anatomic, Age, and Sex Variance in Subjects at Proton MR Spectroscopy—Initial ExperienceRadiology, 2000
- Imaging Evaluation of the Response of High-Grade Osteosarcoma and EwingSarcoma to Chemotherapy with Emphasis on Dynamic Contrast-Enhanced MagneticResonance ImagingSeminars in Musculoskeletal Radiology, 2000
- Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology, 1997
- Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging.RadioGraphics, 1995
- Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathologyMagnetic Resonance in Medicine, 1993
- A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and cholineNMR in Biomedicine, 1991
- Soft-tissue masses: diagnosis using MR imagingAmerican Journal of Roentgenology, 1989
- 1H NMR chemical shift selective (CHESS) imagingPhysics in Medicine & Biology, 1985